Modular Medical announces first patients are using Pivot insulin pump
By HME News Staff
Updated 9:57 AM CDT, Tue June 30, 2026
SAN DIEGO – Modular Medical has announced that the first patients have completed onboarding and training and are now actively using the Pivot tubeless insulin patch pump in real-world settings. The company says this milestone marks the transition of the Pivot pump from development into active patient use and represents a significant step in its commercialization strategy. Modular Medical will now begin collecting real world utilization data and user feedback to support broader adoption and continued product deployment optimization. "Today represents a defining moment for Modular Medical," said Jeb Besser, CEO. "For the first time, patients are using Pivot to manage their insulin therapy, validating our vision of creating a simpler, more accessible pump solution for people who have historically remained on multiple daily injections. This is only the beginning of our efforts to address this substantial market opportunity, and we look forward to gathering real-world data and feedback, as we seek to scale adoption and achieve long-term growth." Modular Medical was founded by Paul DiPerna, a seasoned medical device professional and microfluidics engineer. Prior to founding Modular Medical, he was the founder of Tandem Diabetes in 2005, inventing and designing its t:slim insulin pump. The company previously announced in June that Pivot had received 510(k) clearance from the U.S. Food and Drug Administration (FDA).
Comments